scholarly journals Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma

2019 ◽  
Vol 203 (1) ◽  
pp. 198-207 ◽  
Author(s):  
Ying Liu ◽  
Shengmeng Di ◽  
Bizhi Shi ◽  
Honghong Zhang ◽  
Yi Wang ◽  
...  
2013 ◽  
Vol 2 (2) ◽  
pp. 112-120 ◽  
Author(s):  
Gregory L. Beatty ◽  
Andrew R. Haas ◽  
Marcela V. Maus ◽  
Drew A. Torigian ◽  
Michael C. Soulen ◽  
...  

2013 ◽  
Vol 1 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Evripidis Lanitis ◽  
Mathilde Poussin ◽  
Alex W. Klattenhoff ◽  
Degang Song ◽  
Raphael Sandaltzopoulos ◽  
...  

Blood ◽  
2014 ◽  
Vol 123 (15) ◽  
pp. 2343-2354 ◽  
Author(s):  
Saar Gill ◽  
Sarah K. Tasian ◽  
Marco Ruella ◽  
Olga Shestova ◽  
Yong Li ◽  
...  

Key Points Targeting of CD123 via CAR-engineered T cells results in rejection of human AML and myeloablation in mouse models.


Sign in / Sign up

Export Citation Format

Share Document